Sotera Health (SHC) Competitors $11.61 +0.02 (+0.17%) Closing price 04:00 PM EasternExtended Trading$11.61 0.00 (0.00%) As of 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHC vs. HIMS, GH, OPCH, RDNT, BTSG, SGRY, CON, PRVA, WGS, and VCYTShould you be buying Sotera Health stock or one of its competitors? The main competitors of Sotera Health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Sotera Health vs. Its Competitors Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Hims & Hers Health (NYSE:HIMS) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership. Do institutionals & insiders have more ownership in HIMS or SHC? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 47.6% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, HIMS or SHC? Hims & Hers Health has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Do analysts recommend HIMS or SHC? Hims & Hers Health presently has a consensus price target of $39.58, indicating a potential downside of 22.60%. Sotera Health has a consensus price target of $16.00, indicating a potential upside of 37.81%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the media prefer HIMS or SHC? In the previous week, Hims & Hers Health had 72 more articles in the media than Sotera Health. MarketBeat recorded 74 mentions for Hims & Hers Health and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.00 beat Hims & Hers Health's score of 0.27 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 13 Very Positive mention(s) 3 Positive mention(s) 53 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Neutral Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HIMS or SHC more profitable? Hims & Hers Health has a net margin of 9.24% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat Hims & Hers Health's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.24% 22.75% 15.51% Sotera Health 2.24%41.08%5.68% Which has stronger earnings & valuation, HIMS or SHC? Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B7.75$126.04M$0.6974.12Sotera Health$1.10B2.99$44.34M$0.08145.13 SummaryHims & Hers Health and Sotera Health tied by winning 8 of the 16 factors compared between the two stocks. Get Sotera Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHC vs. The Competition Export to ExcelMetricSotera HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.29B$7.28B$5.50B$8.96BDividend YieldN/A2.80%5.25%4.02%P/E Ratio145.1418.2519.9019.84Price / Sales2.9933.99436.90127.27Price / Cash9.6523.6737.0657.97Price / Book8.126.718.125.62Net Income$44.34M$230.16M$3.16B$248.50M7 Day Performance-0.26%2.49%4.40%5.54%1 Month Performance-6.07%2.98%4.09%7.52%1 Year Performance-2.27%43.09%34.53%22.06% Sotera Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHCSotera Health3.1905 of 5 stars$11.61+0.2%$16.00+37.8%-2.6%$3.29B$1.10B145.143,000HIMSHims & Hers Health2.3704 of 5 stars$49.94+1.1%$39.58-20.7%+138.8%$11.06B$1.48B72.381,637Trending NewsInsider TradeGap UpGHGuardant Health3.8352 of 5 stars$52.04+2.3%$53.76+3.3%+84.3%$6.30B$739.02M-15.352,021Gap UpOPCHOption Care Health4.3329 of 5 stars$32.48+0.7%$35.50+9.3%+15.4%$5.28B$5.00B26.198,088Positive NewsRDNTRadNet3.7847 of 5 stars$56.91-0.4%$69.60+22.3%-6.3%$4.29B$1.83B-132.3511,021Positive NewsBTSGBrightSpring Health Services1.5419 of 5 stars$23.59+0.2%$24.90+5.6%+94.2%$4.14B$11.27B84.2535,000SGRYSurgery Partners2.7445 of 5 stars$22.23+1.3%$33.56+50.9%-3.6%$2.81B$3.11B-14.5315,000CONConcentra Group Holdings Parent2.9469 of 5 stars$20.59-2.6%$28.50+38.4%N/A$2.71B$1.90B15.3711,250PRVAPrivia Health Group4.1986 of 5 stars$23.00+4.5%$27.77+20.7%+26.1%$2.68B$1.74B191.681,140News CoverageAnalyst ForecastHigh Trading VolumeWGSGeneDx3.2431 of 5 stars$92.31+1.3%$90.13-2.4%+203.3%$2.60B$305.45M-65.471,200Analyst ForecastGap UpVCYTVeracyte3.5968 of 5 stars$27.03-1.3%$40.90+51.3%+22.5%$2.14B$445.76M65.93790 Related Companies and Tools Related Companies Hims & Hers Health Competitors Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Surgery Partners Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors GeneDx Competitors Veracyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sotera Health Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Sotera Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
